A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT05169515 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05169515
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2029-08-05
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.